Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart.

Autores de IIS La Fe

• Juan Miguel Sánchez Gómez

  Autor

• 

  Luis Vicente Martínez Dolz

  Autor

• Ignacio José Sánchez Lázaro

  Autor

• Luis Almenar Bonet

  Autor

• María Elena Sánchez Lacuesta

  Autor

• Manuel Portoles Sanz

  Autor

• Jose Miguel Rivera Otero

  Autor

• Carlos Gonzalez Juanatey

  Autor

• Jaume Agüero Ramón-Llin

  Autor

• Francisco Buendía Fuentes

  Autor

• Antonio Salvador Sanz

  Autor

Participantes ajenos a IIS La Fe

• Muñoz-Giner B
• Valera-Román A
• Tejada-Ponce D

Grupos

• Hemostasia, Trombosis, Arteriosclerosis y Biología vascular

Abstract

Cardiac allograft vasculopathy (CAV) is the main cause of graft failure and death 1 year after heart transplantation (HTx). Metabolic syndrome (MS) increases the risk of cardiovascular events by endothelial dysfunction. The purpose of this study was to determine if patients with MS developed a higher risk of CAV 1 year after HTx.